Peroxisome proliferator-activated receptor-alpha expression in rat liver during postnatal development

Area of Science:

• Biochemistry
• Developmental Biology
• Molecular Biology

Background:

• Peroxisome proliferator-activated receptor-alpha (PPARalpha) is a key regulator of lipid metabolism.
• Understanding PPARalpha expression during development is crucial for metabolic health.
• Gene expression patterns can vary significantly across developmental stages.

Purpose of the Study:

• To investigate the developmental expression profile of PPARalpha and related genes in rat liver.
• To compare PPARalpha mRNA and protein levels during fetal, neonatal, and juvenile stages.
• To explore potential common regulatory mechanisms for PPARalpha and PEPCK.

Main Methods:

• Quantitative analysis of PPARalpha, PEPCK, ACO, and apo CIII mRNA levels using RT-PCR.
• Western blotting to assess PPARalpha protein expression.
• Study design included rat liver samples from 19-day fetuses to 1-month-old rats.

Main Results:

• PPARalpha mRNA levels were elevated in neonates compared to fetuses and 1-month-old rats.
• Phosphoenolpyruvate carboxykinase (PEPCK) mRNA expression followed a similar pattern to PPARalpha.
• Acyl-CoA oxidase (ACO) and apolipoprotein CIII (apo CIII) mRNA showed distinct expression profiles.
• PPARalpha protein levels were also increased in suckling rat liver.

Conclusions:

• PPARalpha expression is developmentally regulated in rat liver, peaking in the neonatal period.
• The similar expression patterns of PPARalpha and PEPCK suggest shared regulatory pathways.
• Nutritional and hormonal factors likely play a role in controlling PPARalpha and PEPCK expression during development.